Method of preventing and treating airway remodeling and pulmonary inflammation using A2B adenosine receptor antagonists

Details for Australian Patent Application No. 2005295654 (hide)

International Classifications

Event Publications

10 May 2007 PCT application entered the National Phase

PCT publication WO2006/044610 Priority application(s): WO2006/044610

22 October 2009 Alteration of Name

The name of the applicant has been altered to Gilead Palo Alto, Inc.

14 April 2011 Application Accepted

Published as AU-B-2005295654

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.